Assessing the Longitudinal outcomes of Piperacillin/tazobactam versus ceftriAxone and metronidazole for Children with perforated Appendicitis (ALPACA): A protocol for a pilot randomized controlled trial
Authors
Michael H. Livingston (ORCID: https://orcid.org/0000-0002-0605-1357)
Assessing the Longitudinal outcomes of Piperacillin/tazobactam versus ceftriAxone and metronidazole for Children with perforated Appendicitis (ALPACA): A protocol for a pilot randomized controlled trial
Michael H. Livingston, Mohamed Eltorki, Sarah Khan, Eyal Cohen et al.
Journal
PLoS ONE
Topics
Appendicitis Diagnosis and Management
article
Assessing the Longitudinal outcomes of Piperacillin/tazobactam versus ceftriAxone and metronidazole for Children with perforated Appendicitis (ALPACA): A protocol for a pilot randomized controlled trial
Michael H. Livingston, Mohamed Eltorki, Sarah Khan, Eyal Cohen, Daniel Briatico, Jeffrey M. Pernica, Hélène Flageole, Nadia Safa
article en
Abstract
No abstract available for this paper.
Publication Tag
PLoS ONEVol. 20(11)
Institutions
University of Calgary (CA), University of Toronto (CA), McMaster University Medical Centre (CA), McMaster Children's Hospital (CA), Alberta Children's Hospital (CA), Impact (CA), Alberta Children's Hospital Research Institute, McMaster University (CA)